Related by context. Frequent words. (Click for all words.) 72 non alcoholic steatohepatitis 63 refractory chronic lymphocytic 63 ALN TTR 63 Initiates Phase II 62 Daclizumab 62 Receives Orphan Drug Designation 62 Meets Primary Endpoint 62 active cellular immunotherapy 62 Thiarabine 61 Trofex 61 MKC# 61 inflammatory autoimmune diseases 61 Panzem R 61 Drug Candidate 60 ALN TTR# 60 Factor VIIa 60 Eculizumab 60 Romidepsin 60 VEGFR2 inhibitor 60 2 methoxyestradiol 60 histone deacetylase HDAC inhibitor 60 liposomal formulation 59 Prodarsan ® 59 topical anti infective 59 CEQ# 59 R sorafenib tablets 59 TTR amyloidosis 59 CMV vaccine 59 concerning CombinatoRx 58 cutaneous T 58 Cutaneous T 58 chemotherapy induced neutropenia 58 peripherally acting 58 inflammation autoimmune diseases 57 proteasome inhibitor 57 TELINTRA 57 Diabetic Macular Edema 57 AzaSite Plus 57 Onalta 57 selectively induce apoptosis 57 siRNA therapeutic 57 Fibrillex TM 57 Soliris TM eculizumab 57 Panzem R NCD 57 Kuvan R 57 Completes Enrollment 57 CCX# 56 cardio renal 56 Inhalation Aerosol 56 Mipomersen 56 lysosomal storage disorder 56 immunologic diseases 56 Initiate Phase 56 personalized immunotherapy 56 Myelofibrosis 56 KRN# 56 metastatic colorectal 56 lung pancreatic 56 Gleevec resistant 55 AA amyloidosis 55 multi kinase inhibitor 55 immuno inflammatory diseases 55 Microplasmin 55 castrate resistant prostate cancer 55 carcinoid syndrome 55 phenylketonuria PKU 55 BZL# 55 gastrointestinal mucositis 55 JAK inhibitor 55 novel orally administered 55 inflammatory autoimmune 55 phase IIb clinical 55 postoperative ileus 54 Benign Prostatic Hyperplasia 54 ostarine 54 denufosol tetrasodium 54 Respiratory Syncytial Virus RSV 54 systemically administered 54 paroxysmal nocturnal hemoglobinuria 54 immunological diseases 54 factor VIIa 54 Zoraxel 54 Benign Prostatic Hyperplasia BPH 54 AEG# 54 prophylactic vaccine 54 Hypoactive Sexual Desire Disorder 54 gets USFDA nod 54 opioid induced bowel dysfunction 54 Peyronie Disease 54 Aliskiren 53 adenoviral 53 Pivotal Phase III 53 investigational therapies 53 huC# DM4 53 Rheumatoid Arthritis RA 53 Corlux 53 Phase IIb clinical trials 53 commercializes innovative biopharmaceuticals 53 nicotinic alpha 7 53 FLT3 53 metastatic bone